Scheurer, M. E., Zhou, R., Gilbert, M. R., Bondy, M. L., Sulman, E. P., Yuan, Y., Liu, Y., Vera, E., Wendland, M. M., Youssef, E. F., Stieber, V. W., Komaki, R. R., Flickinger, J. C., Kenyon, L. C., Robins, H. I., Hunter, G. K., Crocker, I. R., Chao, S. T., Pugh, S. L., & Armstrong, T. S. (2022). germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825. Neuro-oncology advances, 4(1), . http://access.bl.uk/ark:/81055/vdc_100168590798.0x000001